MENU
UBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Unity Biotechnology (UBX) Ownership - Who owns Unity Biotechnology?
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
285 East Grand Avenue
Phone
+1 650 416-1192
Employees
32
Web
https://www.unitybiotechnology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.56M
P/E Ratio
N/A
Total Cash
23.23M
Projected Growth
N/A
Total Debt
23.54M
Revenue
N/A
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash/Share
1.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
UBX
Capitalization
16.6M
P/E Ratio
N/A
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash
23.2M
Total Cash/Share
1.38
Total Debt
23.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.49M
P/B Ratio
2.55
Cash Flow
N/A
Earnings
-1.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
2.62
Current Revenue Per Employee
3630.77
Dividends Per Share - Security
N/A
EBITDA
-25.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.29
Shares Held By Institutions
4.28M
Shares Outstanding - Current
16.9M
Total Liabilities
31.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
8.562
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a r&d company of therapeutics to extend the human healthspan
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
285 East Grand Avenue
Phone
+1 650 416-1192
Employees
32
Web
https://www.unitybiotechnology.com